Granahan Investment Management - ENANTA PHARMACEUTICALS INC ownership

ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 199 filers reported holding ENANTA PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.76 and the average weighting 0.1%.

Quarter-by-quarter ownership
Granahan Investment Management ownership history of ENANTA PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$3,090,000
-77.7%
43,414
-76.6%
0.08%
-73.0%
Q4 2021$13,865,000
+33.5%
185,411
+1.4%
0.28%
+44.7%
Q3 2021$10,386,000
+18.0%
182,816
-8.6%
0.20%
+20.1%
Q2 2021$8,801,000
-7.7%
199,970
+3.4%
0.16%
-18.8%
Q1 2021$9,539,000
-1.9%
193,416
-16.3%
0.20%
-7.3%
Q4 2020$9,728,000
+12.9%
231,071
+22.8%
0.22%
-25.3%
Q3 2020$8,614,000
-16.5%
188,164
-8.4%
0.29%
-21.7%
Q2 2020$10,313,000
+35.0%
205,400
+38.2%
0.37%
-9.5%
Q1 2020$7,642,000
-17.1%
148,600
-0.5%
0.41%
-2.8%
Q4 2019$9,223,000
+3.3%
149,293
+0.5%
0.42%
-13.6%
Q3 2019$8,928,000
-26.4%
148,604
+3.3%
0.49%
-18.2%
Q2 2019$12,134,000
-16.1%
143,799
-5.0%
0.60%
-22.7%
Q1 2019$14,454,000
+34.2%
151,322
-0.5%
0.78%
+1.7%
Q4 2018$10,767,000
+21.9%
152,007
+47.1%
0.76%
+59.3%
Q3 2018$8,830,000
-24.3%
103,320
+2.6%
0.48%
-31.9%
Q2 2018$11,668,000
+55.2%
100,670
+8.4%
0.70%
+29.5%
Q1 2018$7,517,000
+42.6%
92,907
+3.4%
0.54%
+30.8%
Q4 2017$5,270,000
+10.3%
89,811
-12.0%
0.42%
+4.3%
Q3 2017$4,776,000
-12.5%
102,041
-32.7%
0.40%
-20.9%
Q2 2017$5,458,000
-10.2%
151,695
-23.2%
0.50%
-17.5%
Q1 2017$6,080,000
-63.4%
197,408
-60.2%
0.61%
+6.8%
Q4 2016$16,617,000
+32.5%
496,025
+5.3%
0.57%
+38.9%
Q3 2016$12,537,000
+37.5%
471,135
+14.0%
0.41%
+23.8%
Q2 2016$9,116,000
-25.5%
413,415
-0.7%
0.33%
-25.4%
Q1 2016$12,230,000
+4.9%
416,425
+18.0%
0.44%
+11.0%
Q4 2015$11,657,000
-20.0%
353,025
-12.5%
0.40%
-11.1%
Q3 2015$14,580,000
+37.8%
403,430
+71.6%
0.45%
+50.8%
Q2 2015$10,578,000235,1300.30%
Other shareholders
ENANTA PHARMACEUTICALS INC shareholders Q3 2018
NameSharesValueWeighting ↓
Krensavage Asset Management, LLC 735,103$8,2113.02%
BRAIDWELL LP 1,038,310$11,597,9230.37%
ARMISTICE CAPITAL, LLC 2,100,000$23,457,0000.36%
FARALLON CAPITAL MANAGEMENT LLC 1,875,000$20,943,7500.10%
PDT Partners, LLC 67,318$751,9420.10%
Virtus ETF Advisers LLC 12,784$142,7970.09%
Portland Global Advisors LLC 34,175$3820.06%
XTX Topco Ltd 27,222$304,0700.05%
Trexquant Investment LP 132,561$1,480,7060.04%
SHERBROOKE PARK ADVISERS LLC 10,100$112,8170.04%
View complete list of ENANTA PHARMACEUTICALS INC shareholders